Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer

Peripheral Neutrophil to Lymphocyte Ratio (NLR), a cogent clinical adjunct for Ki-67 in breast cancer

Abstract Background Clinical utility of Ki-67 immunohistochemistry (IHC) in breast cancer (BC) is mainly limited to decide for the use of chemotherapy and estimate prognosis in patients with either Ki-67 index < 5% or > 30%; however, lacunae still exists pertaining to its analytical validity....

Full description

Bibliographic Details
Main Authors: Radhika Arora, Feroz Alam, Atia Zaka-ur-Rab, Veena Maheshwari, Kiran Alam, Mahboob Hasan
Format: Article
Language:English
Published: SpringerOpen 2023-12-01
Series:Journal of the Egyptian National Cancer Institute
Subjects:
Ki-67
NLR
Breast cancer
Prognosis
Personalized biomarker
Online Access:https://doi.org/10.1186/s43046-023-00200-4

Similar Items

Similar Items